Results 191 to 200 of about 3,324,374 (323)

Ellagic Acid Alleviates Abnormal Fat Reduction by Activating the RXRβ–PPARγ Pathways in a CT26 Tumour‐Induced Cachexia Mouse Model

open access: yesJournal of Cachexia, Sarcopenia and Muscle, Volume 17, Issue 1, February 2026.
ABSTRACT Background Cancer cachexia is a syndrome characterized by significant weight loss, particularly of adipose tissue, which negatively impacts patient survival. Pharmacological approaches to prevent this abnormal fat reduction remain poorly defined.
Woo Yong Park   +12 more
wiley   +1 more source

Blood‐Based Lead Biomarkers and Sarcopenia Indicators in Older Adults

open access: yesJournal of Cachexia, Sarcopenia and Muscle, Volume 17, Issue 1, February 2026.
ABSTRACT Background Chronic exposure to low levels of lead (Pb) remains a widespread public health issue, especially among older adults. While its neurotoxic and cardiovascular effects are well recognized, its potential role in accelerating age‐related musculoskeletal decline is less understood.
Aida Koni   +15 more
wiley   +1 more source

Post-COVID-19 subacute painless thyroiditis: a case report in an anabolic androgenic steroid user. [PDF]

open access: yesBMC Infect Dis
Skrzypiec-Spring M   +3 more
europepmc   +1 more source

Distinct Metabolomic Alterations Are Associated With Physical Function, Weight Loss, and Muscle Mass in Men With Cancer

open access: yesJournal of Cachexia, Sarcopenia and Muscle, Volume 17, Issue 1, February 2026.
ABSTRACT Background Treatments for cancer cachexia, defined as involuntary weight and muscle mass loss leading to significant functional impairment, remain unavailable partly due to insufficient improvement of clinically meaningful outcomes in current trials.
Lindsey J. Anderson   +9 more
wiley   +1 more source

Asian Federation of Osteoporosis Societies 2025 consensus on atypical femoral fractures in patients with osteoporosis. [PDF]

open access: yesOsteoporos Sarcopenia
Valleenukul T   +24 more
europepmc   +1 more source

Evaluation of boldenone undecylenate as an anabolic agent in horses.

open access: green, 1973
John O’Connor   +4 more
openalex  

Circulating Metabolites Treat Human TMJ‐OA by Eliminating Senescent Chondrocytes via the C1QBP/C1q/p14ARF Axis

open access: yesJournal of Extracellular Vesicles, Volume 15, Issue 2, February 2026.
ABSTRACT Temporomandibular joint osteoarthritis (TMJ‐OA) is a progressive degenerative disorder, for which therapeutic interventions remain limited. The disruption of metabolic homeostasis plays a critical role in the pathogenesis and advancement of TMJ‐OA.
Bowen Meng   +19 more
wiley   +1 more source

Bone Optimization for Perioperative Spine Patients: A Multidisciplinary Approach at a Single Academic Center. [PDF]

open access: yesJ Clin Med
Suarez-Nieto MV   +6 more
europepmc   +1 more source

Synthesis and Biological Evaluation of Prostaglandin-F Alkylphosphinic Acid Derivatives as Bone Anabolic Agents for the Treatment of Osteoporosis

open access: green, 2001
David L. Soper   +16 more
openalex   +1 more source

Home - About - Disclaimer - Privacy